//
Jamie M. Sperger - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Hidenori Takagi - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Ashok Singh - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Menno Tamminga - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Sebastian Bender - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Jason Chia-Hsun Hsieh - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Arturo B. Ramirez - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
N/A
N/A
N/A
Sanne de Wit - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Yuichiro Miki - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Yeon-a Choi - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Selena Lin - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
Pembrolizumab
Yilin Li - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Dhananjay Suresh - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Neha Bhagwat - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Paymaneh D. Malihi - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Ophir Vermesh - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Chiara Agnoletto - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
Methadone hydrochloride
Michael Sharma - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
Gemcitabine
Kenneth H. Yu - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
N/A
Jiyeon Ryu - American Association for Cancer Research (AACR) , 2017
Therapeutic Area
Disease
Drug/Treatment
Oncology (ONC)
N/A
Methadone hydrochloride